These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17959582)

  • 1. ASHP therapeutic position statement on antithrombotic therapy in chronic atrial fibrillation.
    Nutescu EA;
    Am J Health Syst Pharm; 2007 Nov; 64(21):2281-91. PubMed ID: 17959582
    [No Abstract]   [Full Text] [Related]  

  • 2. ASHP guidelines on pharmacist-conducted patient education and counseling.
    Am J Health Syst Pharm; 1997 Feb; 54(4):431-4. PubMed ID: 9043568
    [No Abstract]   [Full Text] [Related]  

  • 3. ASHP-PPAG Guidelines for Providing Pediatric Pharmacy Services in Hospitals and Health Systems.
    Eiland LS; Benner K; Gumpper KF; Heigham MK; Meyers R; Pham K; Potts AL
    Am J Health Syst Pharm; 2018 Aug; 75(15):1151-1165. PubMed ID: 29555640
    [No Abstract]   [Full Text] [Related]  

  • 4. ASHP Statement on Telepharmacy.
    Alexander E; Butler CD; Darr A; Jenkins MT; Long RD; Shipman CJ; Stratton TP
    Am J Health Syst Pharm; 2017 May; 74(9):e236-e241. PubMed ID: 28438829
    [No Abstract]   [Full Text] [Related]  

  • 5. ASHP Statement on the Roles of Pharmacy Technicians.
    Schultz JM; Jeter CK; Martin NM; Mundy TK; Reichard JS; Van Cura JD
    Am J Health Syst Pharm; 2016 Jun; 73(12):928-30. PubMed ID: 27261243
    [No Abstract]   [Full Text] [Related]  

  • 6. ASHP Research and Education Foundation's antithrombotic pharmacotherapy traineeship: a trainee's view.
    English DE
    Am J Health Syst Pharm; 2008 Aug; 65(16):1508-10. PubMed ID: 18693202
    [No Abstract]   [Full Text] [Related]  

  • 7. ASHP guidelines on perioperative pharmacy services.
    Bickham P; Golembiewski J; Meyer T; Murray CG; Wagner D
    Am J Health Syst Pharm; 2019 Jun; 76(12):903-820. PubMed ID: 31361851
    [No Abstract]   [Full Text] [Related]  

  • 8. ASHP guidelines on preventing medication errors with chemotherapy and biotherapy.
    Goldspiel B; Hoffman JM; Griffith NL; Goodin S; DeChristoforo R; Montello CM; Chase JL; Bartel S; Patel JT
    Am J Health Syst Pharm; 2015 Apr; 72(8):e6-e35. PubMed ID: 25825193
    [No Abstract]   [Full Text] [Related]  

  • 9. New practitioners' role in achieving the ASHP Health-System Pharmacy 2015 Initiative.
    Campbell RJ
    Am J Health Syst Pharm; 2005 Mar; 62(5):468-9. PubMed ID: 15745908
    [No Abstract]   [Full Text] [Related]  

  • 10. ASHP statement on the role of the medication safety leader.
    Developed through the ASHP Section of Inpatient Care Practitioners Section Advisory Group on Medication Safety and approved by the ASHP Council on Education and Workforce Development on February 21, 2012; by the ASHP Board of Directors on April 13, 2012;
    Am J Health Syst Pharm; 2013 Mar; 70(5):448-552. PubMed ID: 23413170
    [No Abstract]   [Full Text] [Related]  

  • 11. ASHP Practitioner Recognition Program-2016 Fellows of the American Society of Health-System Pharmacists.
    Am J Health Syst Pharm; 2016 Jul; 73(13):1010. PubMed ID: 27325882
    [No Abstract]   [Full Text] [Related]  

  • 12. ASHP professional policy recommendations--invitation to comment.
    Am J Health Syst Pharm; 2005 Apr; 62(7):748-52. PubMed ID: 15790804
    [No Abstract]   [Full Text] [Related]  

  • 13. Urgent statement on antithrombotic therapy of atrial fibrillation.
    Ogawa S; Hori M
    Circ J; 2011; 75(12):2719-21. PubMed ID: 22067930
    [No Abstract]   [Full Text] [Related]  

  • 14. ASHP professional policy recommendations--invitation to comment.
    Am J Health Syst Pharm; 2015 Apr; 72(8):e37-42. PubMed ID: 25825192
    [No Abstract]   [Full Text] [Related]  

  • 15. ASHP Practitioner Recognition Program-2017 Fellows of the American Society of Health-System Pharmacists.
    Am J Health Syst Pharm; 2017 Jul; 74(13):1020. PubMed ID: 28646000
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antithrombotic therapy of atrial fibrillation].
    Mélon P
    Rev Med Liege; 2000 Apr; 55(4):297-301. PubMed ID: 10909317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple antithrombotic therapy for atrial fibrillation and coronary stents.
    Shmyr D; Van der Merwe V; Yakiwchuk E; Barry A; Kosar L
    Can Fam Physician; 2017 May; 63(5):375-381. PubMed ID: 28500198
    [No Abstract]   [Full Text] [Related]  

  • 18. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASHP guidelines on clinical drug research. American Society of Health-System Pharmacists.
    Am J Health Syst Pharm; 1998 Feb; 55(4):369-75. PubMed ID: 9504197
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antithrombotic therapy in atrial fibrillation].
    da Costa JT
    Acta Med Port; 1999; 12(7-11):245-54. PubMed ID: 10707462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.